Préat V - Search Results

1

A novel, smaller scaffold for Affitins: Showcase with binders specific for EpCAM.

Kalichuk V, Renodon-Cornière A, Béhar G, Carrión F, Obal G, Maillasson M, Mouratou B, Préat V, Pecorari F. Kalichuk V, et al. Among authors: preat v. Biotechnol Bioeng. 2018 Feb;115(2):290-299. doi: 10.1002/bit.26463. Epub 2017 Nov 6. Biotechnol Bioeng. 2018. PMID: 28976545

2

High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.

Dasnoy S, Le Bras V, Préat V, Lemoine D. Dasnoy S, et al. Among authors: preat v. Biotechnol Bioeng. 2012 Feb;109(2):502-16. doi: 10.1002/bit.23336. Epub 2011 Oct 16. Biotechnol Bioeng. 2012. PMID: 21928339

3

Targeted nanoparticles with novel non-peptidic ligands for oral delivery.

des Rieux A, Pourcelle V, Cani PD, Marchand-Brynaert J, Préat V. des Rieux A, et al. Among authors: preat v. Adv Drug Deliv Rev. 2013 Jun 15;65(6):833-44. doi: 10.1016/j.addr.2013.01.002. Epub 2013 Feb 20. Adv Drug Deliv Rev. 2013. PMID: 23454185 Review.

4

Chitosan-based siRNA delivery systems.

Ragelle H, Vandermeulen G, Préat V. Ragelle H, et al. Among authors: preat v. J Control Release. 2013 Nov 28;172(1):207-218. doi: 10.1016/j.jconrel.2013.08.005. Epub 2013 Aug 18. J Control Release. 2013. PMID: 23965281 Review.

5

Size Effect on Lipid Nanocapsule-Mediated GLP-1 Secretion from Enteroendocrine L Cells.

Xu Y, Carradori D, Alhouayek M, Muccioli GG, Cani PD, Préat V, Beloqui A. Xu Y, et al. Among authors: preat v. Mol Pharm. 2018 Jan 2;15(1):108-115. doi: 10.1021/acs.molpharmaceut.7b00742. Epub 2017 Dec 15. Mol Pharm. 2018. PMID: 29226685

6

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).

Lemoine D, Francois C, Kedzierewicz F, Preat V, Hoffman M, Maincent P. Lemoine D, et al. Among authors: preat v. Biomaterials. 1996 Nov;17(22):2191-7. doi: 10.1016/0142-9612(96)00049-x. Biomaterials. 1996. PMID: 8922605

7

Polymeric nanoparticles as delivery system for influenza virus glycoproteins.

Lemoine D, Préat V. Lemoine D, et al. Among authors: preat v. J Control Release. 1998 Jun;54(1):15-27. doi: 10.1016/s0168-3659(97)00241-1. J Control Release. 1998. PMID: 9741900

8

Intranasal immunization against influenza virus using polymeric particles.

Lemoine D, Deschuyteneer M, Hogge F, Préat V. Lemoine D, et al. Among authors: preat v. J Biomater Sci Polym Ed. 1999;10(8):805-25. doi: 10.1163/156856299x00892. J Biomater Sci Polym Ed. 1999. PMID: 10487316

9

High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.

Dasnoy S, Dezutter N, Lemoine D, Le Bras V, Préat V. Dasnoy S, et al. Among authors: preat v. Pharm Res. 2011 Jul;28(7):1591-605. doi: 10.1007/s11095-011-0393-x. Epub 2011 Mar 12. Pharm Res. 2011. PMID: 21400018

10

Development of a high-throughput screening platform to study the adsorption of antigens onto aluminum-containing adjuvants.

Jully V, Moniotte N, Mathot F, Lemoine D, Préat V. Jully V, et al. Among authors: preat v. J Pharm Sci. 2015 Feb;104(2):557-65. doi: 10.1002/jps.24256. Epub 2014 Dec 2. J Pharm Sci. 2015. PMID: 25470455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters